Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102M Sell
765,332
-583
-0.1% -$66K 5.59% 4
2026
Q1
$85.3M Buy
765,915
+73,942
+11% +$8.75M 7.23% 3
2025
Q4
$93.3M Sell
691,973
-39,550
-5% -$4.32M 8.28% 2
2025
Q3
$62.1M Buy
+731,523
New +$44.8M 4.8% 7

Other funds holding ABVX

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's ABVX Position: Q2 2026 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reduced its Abivax (ABVX) stake by 0.08% in Q2 2026, selling an estimated $66K and leaving 765,332 shares worth $102M. The position accounts for 5.59% of the portfolio, ranked #4.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 148 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne held 765,332 shares of Abivax worth $102M as of Q2 2026.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 583 Abivax shares in Q2 2026, an estimated $66K.
  • Abivax made up 5.59% of Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's portfolio in Q2 2026, its #4 holding.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 148 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q2 2026, filed 7 Aug 2026.